Related Experiment Videos
Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus
Abstract:
Four isolates of Staphylococcus aureus from patients with endocarditis and bacteremia were capable of secreting high-molecular-weight soluble peptidoglycans when grown in a minimal cell wall medium containing penicillin G. Vancomycin was not able to substitute for penicillin G in triggering this secretion. Secretion reflected de novo synthesis of soluble peptidoglycan and was strongly dependent on time of incubation (30 to 60 min), and number of bacteria (2 X 10(8) to 5 X 10(8) colony-forming units per ml), but not on penicillin G concentration (10 to 250 micrograms/ml). The incorporation of alanine into the peptidoglycans secreted in vitro by these isolates incubated in the presence of penicillin G under optimal conditions was variable. The least incorporation of alanine into peptidoglycan occurred with an isolate from a patient treated with nafcillin who had no detectable antipeptidoglycan titer.
Insights
Staphylococcus aureus secretes soluble peptidoglycans when exposed to penicillin G, a process crucial for understanding bacterial cell wall synthesis and antibiotic resistance mechanisms.
Area of Science:
- Microbiology
- Bacterial Cell Wall Synthesis
- Antibiotic Resistance
Background:
- Staphylococcus aureus is a significant human pathogen causing serious infections like endocarditis and bacteremia.
- Bacterial cell wall synthesis is a primary target for many antibiotics, including penicillin G and vancomycin.
- Understanding the mechanisms of bacterial response to antibiotics is critical for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the secretion of soluble peptidoglycans by Staphylococcus aureus isolates in response to penicillin G.
- To determine the conditions influencing this secretion process.
- To explore the role of alanine incorporation in secreted peptidoglycans.
Main Methods:
- Culturing four Staphylococcus aureus isolates from patients with endocarditis and bacteremia in a minimal cell wall medium.
- Inducing peptidoglycan secretion using penicillin G and testing vancomycin as a substitute.
- Measuring the de novo synthesis of soluble peptidoglycan under varying incubation times, bacterial concentrations, and penicillin G concentrations.
- Analyzing alanine incorporation into secreted peptidoglycans.
Main Results:
- Penicillin G triggered the secretion of high-molecular-weight soluble peptidoglycans by Staphylococcus aureus isolates.
- Vancomycin did not induce this secretion.
- Secretion was dependent on incubation time and bacterial numbers but not penicillin G concentration.
- Alanine incorporation into secreted peptidoglycans varied, with the least incorporation observed in an isolate from a nafcillin-treated patient with no detectable antipeptidoglycan titer.
Conclusions:
- Staphylococcus aureus can secrete soluble peptidoglycans in response to penicillin G, indicating a specific cellular response mechanism.
- This secretion is a de novo synthesis process influenced by specific environmental conditions.
- Variations in alanine incorporation may correlate with prior antibiotic exposure and immune response, suggesting potential implications for treatment outcomes.